Prof Iqbal Razman
Dean & Professor of Pharmacy at the University of Sydney
Professor Iqbal Ramzan is Dean and Professor of Pharmacy at The University of Sydney’s Faculty of Pharmacy. Professor Ramzan is a recognised expert in drug pharmacokinetics/pharmacodynamics, has published 148 refereed papers and provides high-level advice to the Australian Government on drug registration. Professor Ramzan is an international leader in Pharmacy education and is a Past-President of the Asian Association of Schools of Pharmacy and a current President of the Council of Pharmacy Schools – Australia and New Zealand. Professor Ramzan is a Director of the Australian Pharmacy Council and a member of the Australian Pharmacy Leaders Forum. He is a Pharmacist and holds a Diploma from the Australian Institute of Company Directors.
Prof Michael Katz
Director at Ripple Capital
Michael Katz has worked in the academic sector for both the University of Sydney and UNSW, where his focus has been on developing and implementing social investment projects and internship programs within the business faculties, as well as managing action research projects. This includes initiating and managing the Medical Cannabis White Paper developed in collaboration with MGC Pharmaceuticals and Budding Tech.
Senior Lecturer at the University of New South Wales
Selena Griffith is Senior Lecturer at UNSW Sydney. In her current roles as UNSW Engineering Scientia Experience Manager Faculty of Engineering and Senior Lecturer, Centre for Social Impact, Australian School of Business, she is working to design and implement strategies to deliver UNSW 2025 goals with respect to the Scientia Education Experience, particularly around innovation, entrepreneurship and social impact.
Founder and Managing Director of MGC Pharma
Previously CEO of Israel’s second largest licensed Medical Cannabis company, with over 10 years of experience in the global medical cannabis industry and over 15 years of experience in executive roles. Founded MGC Pharmaceuticals to expand into the International markets and to raise the quality and viability of Medicinal Phytocannabinoid products.
Prof Mathew Martin-Iverson
Professor of Medicine & Pharmacology at UWA
Professor Martin-Iverson has published widely on the pharmacological effects of Cannabinoids and Dexamphetamine and has received a number of grants from the NHMRC to further research these effects in recent years.
Chief Operations Officer of MMJ Phytotech
Ms. Catherine Harvey is a highly experienced pharmaceutical industry executive, with an extensive corporate background, having worked for multiple pharmaceutical organisations both domestically and overseas. She held executive leadership positions including Director of Business Development and Corporate Affairs at Mundipharma Pty Limited and Business Development Manager at Norwegian Pharmaceutical company, Nycomed.
Dr Teresa Nicoletti
Partner - Mills Oakley
Dr Teresa Nicoletti leads Mills Oakley’s national IP, Health and Life Sciences team. Teresa is both a lawyer and scientist with more than 20 years’ experience in the pharmaceutical, biotechnology and medical device industries in Australia and New Zealand. She has also worked across a number of other product-related industries, including foods, cosmetics, veterinary pharmaceuticals, agrochemicals and industrial chemicals. More recently, a lot of her work has centered around the developing medicinal cannabis framework at both the Commonwealth and State/Territory levels.
Dr Scott Smid
Senior Lecturer at The University of Adelaide
Dr Scott Smid is a pharmacologist specializing in drug discovery and development research both in the pharmaceutical industry and academia. He maintains a strong research interest in experimental therapeutics applied towards novel treatments for gastrointestinal and neurodegenerative diseases. This includes investigating the biological actions of phytocannabinoids, synthetic cannabinoids and endocannabinoids in areas as diverse as gut function, inflammation and neurodegeneration. He has received US and Australian-based funding to investigate the potential of cannabinoids as novel treatments for inflammation and dementia.
Dr Linda Calabresi
Medical Editor The Medical Republic
Dr Linda Calabresi is the medical editor of the GP publication The Medical Republic and a GP in private practice in Sydney. Linda has been a practising GP for over 20 years. A graduate of The University of Sydney, she started in medical publishing back in the 90s. She is also a medical editor with HealthEd, a medical education organisation. She is a passionate advocate for high-quality primary care and its role in improving patients' quality of life.
Director at Health House International
Paul is a pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada and Israel.
Dr Stewart James Washer
Executive Director of Zelda Therapeutics
Stewart has 25 years of CEO and Board experience in medical and agrifood biotech companies. He is currently the Executive Director of Zelda Therapeutics Ltd (ASX:ZLD) in the medicinal cannabis space, Chairman of Orthocell Ltd (ASX:OCC), a regenerative medicine company, Director of Cynata Therapeutics Ltd (ASX:CYP) who are developing stem cell therapies and Chairman of Minomic International Ltd. He is also a founder of AusCann Ltd (ASX:AC8) in the medicinal cannabis space, and a founder of Firefly Health, developing a digital health device for diabetes. He was also a Senator with Murdoch University and was a Director of AusBiotech Ltd.
Co-Founder and CEO of Under The Tree BioPharmaceuticals
Sergio has practical experience and knowledge of GxP environments (e.g. GMP, GLP) regulating the Pharmaceutical sector. He started his career in BioPharmaceuticals working for CSL Behring in Australia (Plasma Fractionation Industry), while studying a Master Degree in Biomedical Engineering at the University of Melbourne, and was later hired as a process engineer. Before starting up UTT in 2015, he worked as lead project manager and process engineer at Kedrion SPA (Italy).
Prof Torbjorn Falkmer
Dean of Research Faculty of Health Sciences at Curtin University
Program Director Autism CRC
Professor Torbjorn Falkmer (PhD in Medicine) has a background in traffic safety research regarding vulnerable road transport system users, for example, children and adults with and without disabilities and older road users. As part of this research, visual perception and cognition have been in focus. In 2009 he received a competitive and prestigious Research Fellowship at Curtin University, School of Occupational Therapy and Social Work on a research program on Visual perceptual abilities in Asperger syndrome. He is one Program Director in the Autism CRC (), Since 2016 he is Dean of Research and Graduate Studies in the Faculty of Health Sciences of Curtin University.
Leah Bisiani is a highly skilled registered nurse/dementia consultant, having completed her Masters in Health Science/dementia stream, inclusive of her diploma in Business/Frontline Management, with more than 25 years’ experience in aged care/dementia specific care. Leah has won multiple awards such as the Lend-Lease Australian and Global Award for “Excellence in Innovation” and for her person-centred and behaviour management models of care designed for people living with dementia.
Dr Greg Doran
Lecturer at Charles Sturt University
Dr Greg Doran completed a BSc at Latrobe University, majoring in chemistry/biochemistry, followed by a Masters in inorganic analytical spectroscopy at RMIT University. He then worked for a short period as a laboratory chemist with CSIRO before returning to university to undertake a PhD at Charles Sturt University investigating the environmental fate of pesticides in rice bays. After completing his PhD, Greg was appointed as a lecturer in chemistry at CSU and now works in the School of Agricultural and Wine Sciences teaching undergraduate chemistry.
Founder of Indicated Technology
Founder of Indicated Technology Pty Ltd and botanical specialist; Tom is passionate about helping to enhance Australian medical cannabis cultivation standards. Tom has spent the past 5 years working in the horticultural sector whilst studying production horticulture, hydroponics and plant botany at a university level. He is also a featured author for multiple indoor gardening magazines with articles published in the US, UK, Canada and Europe.
Dr Stephen Bright
Senior Lecturer Addiction at Edith Cowan University
Dr Stephen Bright has worked as a psychologist within the Mental Health & AOD field for the past 15 years. He is currently Senior Lecturer of Addiction at Edith Cowan University. Stephen is a strong advocate of harm reduction and an evidence-based approach to AOD legislation. He is also interested in the role of certain illicit substances to facilitate psychotherapy and treat medical conditions. He is an Adjunct Research Fellow with Curtin's National Drug Research Institute, and Vice-President of Psychedelic Research In Science & Medicine (PRISM), a not-for-profit charity that aims to initiate, fund and support research into the use of currently prohibited drugs for therapeutic use. Stephen has published a range of papers on novel psychoactive substances such as synthetic cannabis, drug policy, psychedelic science, brief interventions and psychometric analysis.
General Manager of Director at Vitro Software International
Berne is the Chair of the AIIA Health Special Interest Group, a member of the Dean of Health Advisory Board at UTS and an Assoc Professor of Healthcare Industry at UTS. She is a member of the Chris O’Brien Lifehouse Integrative Medicine Committee, as well as a Board member of the NFP organisation Pathfinders with a special interest in registering the Births of Aboriginal people. Berne worked with the Australian Digital Health Agency delivering a strategic Framework for Interoperability for healthcare systems in Australia. Berne is currently Director of Vitro Software is a leading international technology company that provides technology & services that drive efficiencies and quality in healthcare.
Dr Nitin Mantri
Senior Lecturer at Royal Melbourne Institute Technology
Dr Nitin Mantri is a Senior Lecturer in Biotechnology at RMIT University. He is an expert in Functional Biology and Pharmacogenomics. His research involves using contemporary molecular tools like Next-Generation Sequencing for identifying genes and alleles responsible associated with traits of importance. In the last 5 years, he has attracted over $3.5 million in research funding from the ARC, HIAL, DIISRTE, Industry collaborators and RMIT University. In the last 10 years, he has published over 55 research articles, mostly in high-impact journals. He is on Editorial Board of Scientific Reports, Frontiers of Plant Sciences, Journal of Ayurveda and Integrative Medicine, International Journal of Traditional and Complementary Medicine, and Combinatorial Chemistry & High Throughput Screening.